tiprankstipranks
Trending News
More News >
AEON Biopharma (AEON)
:AEON
US Market

AEON Biopharma (AEON) Income Statement

Compare
219 Followers

AEON Biopharma Income Statement

Last quarter (Q3 2025), AEON Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, AEON Biopharma's net income was $-4.54M. See AEON Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Operating Expenses
$ -72.98M$ 348.09M$ 48.43M$ 65.85M$ 18.91M
Depreciation and Amortization
$ 97.00K$ 99.00K$ 68.00K$ 3.00K$ 875.00K
EBITDA
$ -27.73M$ -52.74M$ -48.36M$ -36.88M$ -15.51M
Operating Income
$ 72.98M$ -348.09M$ -48.43M$ -65.85M$ -16.39M
Other Income/Expenses
$ -30.98M$ -36.55M$ -4.13M$ 10.21M$ -16.52M
Pretax Income
$ 42.01M$ -384.63M$ -52.56M$ -55.64M$ -32.91M
Net Income
$ 42.01M$ -384.63M$ -52.56M$ -55.64M$ -32.91M
Per Share Metrics
Basic EPS
$ 77.74$ -4.99$ -27.25$ -31.73$ -547.60
Diluted EPS
$ 72.93$ -4.99$ -27.25$ -31.73$ -547.60
Weighted Average Shares Outstanding
575.00K 77.07M 1.93M 1.75M 60.00K
Weighted Average Shares Outstanding (Diluted)
575.95K 77.07M 1.93M 1.75M 91.62K
Currency in USD

AEON Biopharma Earnings and Revenue History